Cynata Receives IRB Approval for aGvHD Clinical Trial
Filed with ASX · · 2 pages · English
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Notice of Acceptance for Cynata Australian Patent
- Cynata Receives $1.65m R&D Tax Incentive Refund
- Notice of Allowance for Cynata US Patent
- New Kidney Transplantation Clinical Trial for Cynata & LUMC
- Notice of Allowance for Australia & Canada Cymerus Patents
Later from Cynata Therapeutics
- Cynata Adds New Sites for DFU Clinical Trial
- Cynata completes $5.0m Placement and launches SPP
- Capital Raising Presentation
- Ethics Committee Approval for Proposed aGvHD Phase 2 Trial
- Share Purchase Plan Booklet & Option Prospectus
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics